Faron to Present at H.C. Wainwright BioConnect
TURKU – FINLAND, January 4, 2021 – Faron Pharmaceuticals Ltd (“Faron”) (LON: FARN), the clinical stage biopharmaceutical company, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron Pharmaceuticals, will present in a pre-recorded presentation at the virtual H.C. Wainwright BioConnect Conference that will be available on-demand starting Monday, January 11, 2021 at 6:00 a.m. ET. An audio webcast of the presentations will be available in the “Investors” section on Faron’s website at https://www.faron.com/investors ENDS For more information please contact: